Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes
Public ClinicalTrials.gov record NCT03081455. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Evaluation of the Impact of a Process Engineering Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes in Community-Based Obstetrics and Gynecology Settings
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective, non-interventional study to evaluate the impact of a process engineering intervention on screening and testing outcomes for common hereditary cancer syndromes in community-based OB/GYN settings.
Study identification
- NCT ID
- NCT03081455
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 145 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 12, 2017
- Primary completion
- Jul 6, 2017
- Completion
- Aug 3, 2017
- Last update posted
- Aug 7, 2017
2017
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Westwood Women's Health | Waterbury | Connecticut | 06708 | — |
| Associates for Women's Medicine | Syracuse | New York | 13203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hereditary Cancer trials
Other public records listing Hereditary Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07618520: Expanding Genetic Access for Prostate Cancer Survivors Not yet recruiting
- NCT06895681: UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations Not yet recruiting
- NCT06708429: Lynch Syndrome X-Talk of Enteral Mucosa With Immune System Recruiting
- NCT06157801: Evaluation of Hereditary Cancer Educational Videos Active, not recruiting
- NCT06073626: Addressing Genomic Disparities in Cancer Survivors Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03081455, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2017 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03081455 live on ClinicalTrials.gov.